Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells
Drug repurposing is a cost-effective and innovative strategy for identifying new therapeutic applications for existing drugs, thereby shortening development timelines and accelerating the availability of treatments. Applying this approach to the development of cosmeceutical ingredients enables the c...
Saved in:
| Main Authors: | Ye-Jin Lee, Chang-Gu Hyun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/4/900 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Melanogenic Effects of L-Theanine on B16F10 Cells and Zebrafish
by: Chih-Li Yu, et al.
Published: (2025-02-01) -
Umckalin Promotes Melanogenesis in B16F10 Cells Through the Activation of Wnt/β-Catenin and MAPK Signaling Pathways
by: So-Yeon Oh, et al.
Published: (2025-04-01) -
Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health
by: Hyeon-Mi Kim, et al.
Published: (2025-02-01) -
Anti-melanogenic effects of hydroxyethyl chrysin through the inhibition of tyrosinase activity: In vitro and in silico approaches
by: Yuna Lee, et al.
Published: (2025-01-01) -
Bee pollen peptides as potent tyrosinase inhibitors with anti-melanogenesis effects in murine b16f10 melanoma cells and zebrafish embryos
by: Papassara Sangtanoo, et al.
Published: (2024-12-01)